Assurex Health buyer has a Cincinnati connection

Story excerpt provided by Cincinnati Business Courier.

Written by Barrett J. Brunsman.

Myriad Genetics, the Utah firm that agreed to buy Mason-based Assurex Health in a deal that could be worth up to $410 million, has a Cincinnati connection.

Dr. Rick Wenstrup, chief medical officer of Myriad (NASDAQ: MYGN), helped invent the technology that Assurex Health’s genetic tests are based on when he was a professor at Cincinnati Children’s Hospital Medical Center.

Click here to read the complete article.

Originally published August 16, 2016.